Do GLP-1 medications cause electrolyte imbalances directly?

Mainly indirectly. The best-documented route is secondhand: vomiting and diarrhea deplete sodium, potassium, and magnesium the same way any GI illness would. Two small, short studies hint at a direct effect, but weakly: a 3-hour GLP-1 infusion increased urinary sodium excretion, and in a 20-person study of dulaglutide, fluid intake was lower than on placebo but the difference did not reach statistical significance (p = 0.06) and blood sodium was unchanged. Neither study showed an electrolyte problem.

How common are GI side effects that could cause electrolyte loss on a GLP-1?

Per the FDA labels: on Wegovy 2.4 mg, nausea was reported in 44% of adults, diarrhea in 30%, and vomiting in 24% (versus 16%, 16%, and 6% on placebo). On Zepbound, depending on dose, nausea was reported in 25–29%, diarrhea in 19–23%, and vomiting in 8–13% (versus 8%, 8%, and 2% on placebo). These come from separate trials, so they aren't a head-to-head comparison.

What symptoms suggest an electrolyte problem, not just normal side effects?

Muscle cramps, unusual weakness or fatigue, heart palpitations, confusion, dizziness on standing, or a headache that doesn't fit your usual pattern are worth raising with your prescriber — especially alongside vomiting or diarrhea that isn't going away. If you can't keep fluids down, call your prescriber the same day rather than waiting for your next appointment.

Does calorie restriction alone cause electrolyte problems?

It can contribute, but it works differently. Eating less doesn't flush sodium and potassium out of your body the way vomiting and diarrhea do — it lowers how much comes in. A 2025 joint advisory from four nutrition and obesity societies notes that the large drop in food intake on GLP-1s can lead to insufficient intake of essential minerals, magnesium among them. So reduced intake is a slower, secondary contributor; GI fluid loss is the main one.

Can GLP-1 Coach's food log tell me my exact electrolyte intake?

No — and it doesn't claim to. The photo-scan food log gives a directional estimate for sodium, potassium, and magnesium alongside protein, the same way it estimates protein: useful for spotting a pattern over days and weeks, not a precise lab-grade number. Preparation — added salt, sauces, cooking method — isn't visible in a photo, so treat the numbers as a rough guide, not a measurement.

Should I be taking electrolyte supplements on a GLP-1?

That depends on your individual GI symptom burden, kidney function, blood pressure, and any medications you're on (diuretics and blood pressure medications both interact with electrolyte status). None of the sources behind this article — the FDA labels or the 2025 joint nutrition advisory — recommend routine electrolyte supplements for GLP-1 users. This is a conversation for your prescriber, not a default recommendation — some electrolyte supplements can be harmful for people with kidney disease or on certain heart medications.

Electrolytes on GLP-1: Sodium, Potassium & Magnesium Risks

Q: Why do I need electrolytes on a GLP-1?

Because the most common GLP-1 side effects — nausea, vomiting, and diarrhea — cause fluid loss, and sodium, potassium, and magnesium leave the body with that fluid. Eating and drinking less on top of that means less coming back in. FDA labels for Wegovy and Zepbound warn about dehydration from these side effects; they don't mention electrolytes by name, so the electrolyte link is physiological reasoning plus case reports rather than a labeled warning.

Written by the GLP-1 Coach editorial team. Last updated October 1, 2026.

Most of the GLP-1 conversation around nutrition focuses on protein — for good reason. But there's a second, less-discussed risk that's specific to how these medications commonly make people feel, not just how much they make people eat: electrolyte depletion.

This article is careful about what is and isn't established. The dehydration risk is on the FDA labels. The electrolyte risk is a reasonable step beyond that — well-grounded in physiology and documented in case reports — but it is not itself a labeled warning, and we say so below.

Why do I need electrolytes on a GLP-1?

Short answer: because the most common GLP-1 side effects make you lose fluid, and sodium, potassium, and magnesium leave with it — while a smaller appetite means less of all three coming back in.

There are two parts to that:

Losses go up. Vomiting and diarrhea carry electrolytes out of the body. This is the main route.
Intake goes down. Eating and drinking less means fewer minerals and less fluid coming in. This is a slower, secondary contributor.

"Needing electrolytes" doesn't automatically mean needing a supplement or a drink mix. For most people it means drinking enough, eating mineral-rich foods when appetite allows, and knowing when GI symptoms have crossed from unpleasant into something your prescriber should hear about.

How do GI side effects deplete electrolytes?

When you vomit, you lose stomach acid along with fluid. The resulting drop in blood volume triggers the kidneys to hold on to sodium — and in the process they excrete potassium, sometimes more than was lost in the vomit itself, while the body drifts toward alkalosis. When you have diarrhea, fluid moves through the gut too fast to be reabsorbed, and the Merck Manual lists the consequences directly: fluid loss with dehydration and loss of sodium, potassium, magnesium, and chloride, with low potassium in severe or chronic diarrhea and low magnesium after prolonged diarrhea. This is general GI physiology — the same mechanism behind why any stomach bug leaves you drained and crampy, not just hungry.

GLP-1 medications are relevant because of how common these side effects are. The figures below are from the adverse-reaction tables in the current FDA prescribing information:

	Nausea	Diarrhea	Vomiting
Wegovy 2.4 mg (semaglutide)	44%	30%	24%
Placebo in the Wegovy trials	16%	16%	6%
Zepbound 5 / 10 / 15 mg (tirzepatide)	25% / 29% / 28%	19% / 21% / 23%	8% / 11% / 13%
Placebo in the Zepbound trials	8%	8%	2%

These come from separate trial programs with different populations, so they aren't a head-to-head comparison. On the Wegovy label, 4.3% of adults stopped treatment because of a GI side effect, versus 0.7% on placebo. Both labels tell prescribers to follow the gradual dose-escalation schedule specifically to reduce GI side effects, and to watch most closely during dose initiation and escalation — which is when a stretch of repeated GI symptoms, combined with eating and drinking less, is most likely to add up.

What do the FDA labels actually say?

The Wegovy and Zepbound labels both carry a warning titled "Acute Kidney Injury Due to Volume Depletion." Both say there have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, and that the majority occurred in patients who had GI side effects leading to dehydration. The patient Medication Guides put it plainly: diarrhea, nausea, and vomiting may cause a loss of fluids, it is important to drink fluids to reduce the chance of dehydration, and you should tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.

What the labels don't say matters just as much. Neither label mentions electrolytes, potassium, sodium, or magnesium as a risk anywhere. The labeled warnings cover dehydration, volume depletion, and kidney injury. The step from "these drugs commonly cause vomiting and diarrhea" to "vomiting and diarrhea deplete electrolytes" is physiological reasoning supported by case reports — not something the FDA has put on the label, and not something any trial we found has measured as a rate in GLP-1 users.

A 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society lands in the same place: dehydration from severe nausea, vomiting, or diarrhea can cause acute kidney injury and heart palpitations, "so efforts should be made to prevent dehydration." Its dietary guidance is to ensure adequate fluids. It does not recommend routine electrolyte monitoring or supplementation.

Do GLP-1s affect electrolytes directly?

Mainly indirectly — but "not at all" would overstate it. Two small human studies hint at a direct effect on sodium and fluid handling, one more convincingly than the other:

Sodium excretion. In a crossover study of 15 healthy subjects and 16 men with obesity, a 3-hour intravenous infusion of GLP-1 after a salt load increased urinary sodium excretion (Gutzwiller et al., 2004). That was the natural hormone infused for a few hours, not a weekly medication taken for months.
Fluid intake — a weak, inconclusive signal. A crossover study of 20 healthy volunteers given dulaglutide for three weeks (Winzeler et al., 2020) found lower median fluid intake during a supervised 8-hour visit — 1,300 ml versus 1,600 ml on placebo — but that difference did not reach statistical significance (p = 0.06), and blood sodium was unchanged, at 140 mmol/L on both arms. Participants reported no difference in thirst; 24-hour urine output was lower on dulaglutide (p = 0.04). This study does not show that GLP-1s reduce fluid intake, and it shows no effect on electrolytes at all.

Both studies are small and short, neither used semaglutide or tirzepatide, and neither showed an electrolyte problem. Taken together they're a reason not to state flatly that GLP-1s have no direct effect — not evidence that they have one that matters clinically. The practical takeaway doesn't depend on them: on a rough GI week, drink deliberately rather than waiting for thirst.

Does eating less affect electrolytes too?

Yes, but differently. Cutting calories doesn't flush sodium and potassium out of your body the way vomiting and diarrhea do. What it does is lower how much comes in — potassium and magnesium come from food, and less food means less of both.

The 2025 joint advisory notes that people on GLP-1s for obesity typically reduce calorie intake by 16–39%, and that a reduction this large and fast "can lead to insufficient intakes of essential vitamins and minerals," particularly at very low intakes. Magnesium is on its list of nutrients of concern. So reduced intake is a real but slower contributor: on its own it's a gradual shortfall, and combined with a week of GI symptoms it means you're losing more while replacing less.

How serious can it get?

Rarely, very. A 2025 case report describes a 57-year-old woman — who also had hypertension and irritable bowel syndrome — whose tirzepatide dose was raised from 10 mg to 15 mg. Over the following two weeks she had persistent nausea, vomiting, and diarrhea, then went into cardiac arrest from ventricular fibrillation. Her potassium was 2.2 mEq/L (normal 3.4–4.9) and her magnesium 1.1 mg/dL (normal 1.9–2.7). She was resuscitated, her electrolytes were replaced, and she recovered. The authors concluded that the GI side effects and resulting electrolyte disturbances were the primary precipitating factors.

This is one patient, published as a single case report. It is not a typical outcome and it says nothing about how often this happens. It's included because it shows what the far end of the pathway looks like — and because the two weeks of unrelenting GI symptoms that preceded it are exactly the situation the label tells you to report.

What symptoms are worth telling your prescriber about?

Most electrolyte fluctuations on a GLP-1 are mild and self-correct with normal eating and hydration. The signs worth flagging — particularly if they follow a stretch of vomiting, diarrhea, or noticeably reduced food and fluid intake — include:

Muscle cramps or unusual weakness, especially in the legs
Heart palpitations or a noticeably irregular heartbeat
Confusion, unusual fogginess, or dizziness on standing
A headache pattern that doesn't fit your normal one
Persistent fatigue that doesn't track with sleep or activity

None of these are exclusive to electrolyte problems — they overlap with dehydration, low blood sugar, and plain fatigue. That's exactly why they're worth mentioning rather than self-diagnosing: a basic metabolic panel is a simple way for a prescriber to rule electrolytes in or out.

How quickly to act:

Call your prescriber today if you can't keep fluids down, or if nausea has been severe for two days in a row. Don't wait for your next scheduled appointment. This is the same threshold GLP-1 Coach uses in the app: a check-in note saying you can't keep fluids down, or nausea logged at 7/10 or higher two days running, switches the day's coaching to "call your prescriber today."
Tell your prescriber promptly about nausea, vomiting, or diarrhea that isn't going away, even if you're still managing to drink — that is the wording on the Medication Guide.
Get urgent medical attention for fainting, chest pain, severe confusion, or a very irregular heartbeat.

Does this mean everyone on a GLP-1 needs electrolyte supplements?

No — and this isn't a "take electrolytes just in case" post. None of the sources here recommend routine supplementation for GLP-1 users. It also isn't safe for everyone: people with kidney disease, certain heart conditions, or who are on diuretics or blood pressure medications can be harmed by electrolyte supplements taken without guidance, since those same drugs already shift sodium and potassium balance. Whether supplementation makes sense for you depends on your GI symptom pattern, kidney function, and current medications — a conversation for your prescriber, not a default.

What is reasonable for most people: drinking fluids deliberately rather than waiting for thirst, getting potassium and magnesium from food when appetite allows, and treating several days of GI symptoms as a reason to contact your prescriber rather than something to push through.

Which foods provide potassium and magnesium?

Food is the default source, and several options are small-portion and protein-compatible — useful when appetite is low. The numbers are estimates — see the note under the table.

Food	Portion	Potassium	Magnesium
Baked potato, with skin	1 medium (173 g)	926 mg	48 mg
Avocado	100 g (about half)	485 mg	29 mg
Banana	1 medium (118 g)	422 mg	32 mg
Spinach, cooked	½ cup (90 g)	419 mg	78 mg
Plain low-fat yogurt	170 g (6 oz)	398 mg	29 mg
Lentils, cooked	½ cup (99 g)	365 mg	36 mg
Salmon, cooked	85 g (3 oz)	326 mg	26 mg
Black beans, cooked	½ cup (86 g)	305 mg	60 mg
Pumpkin seeds, roasted	28 g (1 oz)	221 mg	154 mg
Almonds	28 g (1 oz)	205 mg	76 mg

About these numbers: they are our own estimates, not figures published by the USDA. Each is the per-100 g potassium or magnesium value from the USDA FoodData Central SR Legacy database, multiplied by a standard serving weight we chose and rounded. Actual content varies with variety, preparation, and portion size. To check a value, search the database for the entry by its FDC ID: baked potato 170093, avocado 171705, banana 173944, cooked spinach 168463, plain low-fat yogurt 170886, cooked lentils 172421, cooked Atlantic salmon 175168, cooked black beans 173735, roasted pumpkin seeds 170557, almonds 170567.

For scale: the adequate intake for potassium is 3,400 mg a day for adult men and 2,600 mg for adult women, and the recommended magnesium intake is 400–420 mg for men and 310–320 mg for women. Those are general-population reference values, not GLP-1-specific targets, and not goals to chase on a day when you can barely eat. If you have kidney disease or take medications that raise potassium, ask your prescriber before deliberately increasing potassium — including from food.

Sodium isn't in the table because preparation, not the food itself, drives most of it — which is also why it's the hardest of the three to estimate.

How GLP-1 Coach's food log fits in

Our photo-scan food log — the same feature that estimates protein from a photo of your meal — also surfaces a directional estimate for sodium, potassium, and magnesium alongside the protein number. The goal is the same as the protein estimate: give you a rough signal you can track over days and weeks, not a lab-grade number.

The same honesty framing that applies to the protein estimate applies here, and it matters more for sodium specifically: preparation isn't visible in a photo. Two visually identical plates of chicken and rice can differ widely in sodium depending on how much salt, sauce, or seasoning went into the cooking — something no photo can show. So the app treats sodium as a rough directional estimate, not a precise measurement, and will often show a range or a low/moderate/high band rather than a single confident number. Potassium and magnesium tend to track more reliably with what food actually is (a banana is a banana), so those estimates carry a bit more confidence — but they're still estimates, not a substitute for a lab test.

The point of the feature isn't to replace bloodwork or medical monitoring. It's to make the pattern visible — if your logged meals have shown low potassium three days running, alongside symptoms you'd otherwise brush off, that's useful context to bring to your prescriber, not a diagnosis on its own.

Already tracking with GLP-1 Coach? Snap a photo of your next meal in the daily check-in — protein and electrolyte estimates show up side by side, no extra logging step required.

The bottom line

Bottom line: You need to pay attention to electrolytes on a GLP-1 mainly because its common GI side effects — nausea, vomiting, diarrhea — cause fluid loss, and sodium, potassium, and magnesium go with it; eating and drinking less adds to the gap. FDA labels warn about dehydration and kidney injury from these side effects but never mention electrolytes by name, so treat the electrolyte link as sound physiology backed by case reports, not a labeled warning. It isn't a reason for blanket supplementation. Drink deliberately, lean on potassium- and magnesium-rich foods, know the warning signs — and if you can't keep fluids down, call your prescriber that day.

Final Thoughts

Electrolytes get less attention than protein in the GLP-1 conversation, but the underlying logic is the same: these medications create conditions — appetite suppression, GI side effects, reduced intake — that make it easier to drift into a deficit without noticing. Protein needs on GLP-1s covers the muscle-preservation side of that equation in depth (our protein calculator gives you a starting target); electrolytes are the fluid-and-mineral side of it.

GI side effects are most likely around dose changes, so those are the weeks to pay closest attention. The side effects comparison covers how nausea and GI symptoms differ between semaglutide and tirzepatide, and if you're restarting after a break, the restarting Ozempic guide covers how they often reappear during re-titration.

Neither protein nor electrolytes are things to obsess over daily. They're things worth having a rough, ongoing sense of — so that if something's actually drifting, you notice it in week two instead of week eight.

Related:

This article is educational and not a substitute for medical advice. Electrolyte imbalances can be serious — if you can't keep fluids down, call your prescriber the same day; persistent vomiting, diarrhea, or the symptoms described above are worth raising with your prescriber promptly; and severe symptoms (fainting, chest pain, severe confusion, a very irregular heartbeat) warrant urgent medical attention.

Sources: Wegovy (semaglutide) prescribing information, FDA, revised 02/2026; Zepbound (tirzepatide) prescribing information, FDA, revised 02/2026; Mozaffarian et al., Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory, Obesity 2025; Do et al., Dysnatremia in Gastrointestinal Disorders, Frontiers in Medicine 2022; Diarrhea, Merck Manual Professional Edition; Electrolyte Imbalance, Cleveland Clinic; Gutzwiller et al., Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men, J Clin Endocrinol Metab 2004; Winzeler et al., Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers, Endocrine 2020; Kammaripalle et al., Life-Threatening Ventricular Fibrillation Linked to High-Dose Tirzepatide-Induced Gastrointestinal Side Effects, Cureus 2025; Dietary Reference Intakes for Sodium and Potassium, National Academies 2019; Magnesium in diet, MedlinePlus.

Electrolytes and GLP-1: Why GI Side Effects Put Sodium, Potassium & Magnesium at Risk